Life AI Net
ホーム
アーカイブ
計算ツール
ディレクトリ
ニュースレター
ログイン
日本語
English
简体中文
Deutsch
Français
Español
日本語
한국어
العربية
Auto
ホーム
アーカイブ
計算ツール
ディレクトリ
ニュースレター
English
简体中文
Deutsch
Français
Español
日本語
한국어
العربية
Auto
ログイン
ホーム
アーカイブ
計算ツール
ディレクトリ
More
ライブ
Lonza News
Stipple Bio taps Lonza platform to advance ADC pipeline - The Pharma Letter
Cell
Single-cell mapping of regulatory DNA-protein interactions
Cell
Plasma signals of lung tumor promotion for molecular cancer prevention
Cell
Deep learning of functional perturbations from condensate morphology
FierceBiotech
At first public hearing for FDA’s CNPV program, industry support meets ‘deep concern’ from experts
Lonza News
Stipple Bio taps Lonza platform to advance ADC pipeline - The Pharma Letter
10x Genomics Blog
10x Genomics Stock On Fire: Up 41% With 8-Day Winning Streak - Trefis
Labiotech
Episode 200 Special: Joachim Eeckhout on building Labiotech and the future of biotech media
Lonza News
Lonza and Stipple Bio partner to advance next-generation precision oncology ADC therapies - Indian Pharma Post
Eli Lilly
Gilead, Merck, Eli Lilly lead $106B biopharma takeover wave in 2026 - MSN
Thermo Fisher
The Bull Case For Thermo Fisher Scientific (TMO) Could Change Following AI-Enhanced Orbitrap Drug Discovery Launches – Learn Why - Yahoo Finance
eLife
The NTR/prodrug revolution: Tools for controlling cell loss and regeneration
Lonza News
Stipple Bio taps Lonza platform to advance ADC pipeline - The Pharma Letter
Cell
Single-cell mapping of regulatory DNA-protein interactions
Cell
Plasma signals of lung tumor promotion for molecular cancer prevention
Cell
Deep learning of functional perturbations from condensate morphology
FierceBiotech
At first public hearing for FDA’s CNPV program, industry support meets ‘deep concern’ from experts
Lonza News
Stipple Bio taps Lonza platform to advance ADC pipeline - The Pharma Letter
10x Genomics Blog
10x Genomics Stock On Fire: Up 41% With 8-Day Winning Streak - Trefis
Labiotech
Episode 200 Special: Joachim Eeckhout on building Labiotech and the future of biotech media
Lonza News
Lonza and Stipple Bio partner to advance next-generation precision oncology ADC therapies - Indian Pharma Post
Eli Lilly
Gilead, Merck, Eli Lilly lead $106B biopharma takeover wave in 2026 - MSN
Thermo Fisher
The Bull Case For Thermo Fisher Scientific (TMO) Could Change Following AI-Enhanced Orbitrap Drug Discovery Launches – Learn Why - Yahoo Finance
eLife
The NTR/prodrug revolution: Tools for controlling cell loss and regeneration
アーカイブ
この記事はアーカイブに存在しません。